Reply to the 'Comment on "Investigation of Zr(IV) and 89 Zr(IV) complexation with hydroxamates: progress towards designing a better chelator than desferrioxamine B for immuno-PET imaging"' by A. Bianchi and M. Savastano, Chem. Commun., 2020, 56, D0CC01189D - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Chemical Communications Year : 2020

Reply to the 'Comment on "Investigation of Zr(IV) and 89 Zr(IV) complexation with hydroxamates: progress towards designing a better chelator than desferrioxamine B for immuno-PET imaging"' by A. Bianchi and M. Savastano, Chem. Commun., 2020, 56, D0CC01189D

Abstract

The alternative analysis of A. Bianchi and M. Savastano is a valuable contribution to the understanding of the complex systems at stake in the complexation chemistry of Zr4+ by considering polynuclear species. Placed in the context of nuclear medicine where such aggregates are unlikely and considering recent literature data, this however points out that no clear agreement exists to describe such complex formation.

Domains

Cancer
Fichier principal
Vignette du fichier
PapierGuerardAccepte.pdf (439.09 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

inserm-02947405 , version 1 (26-10-2021)

Identifiers

Cite

François Guérard, Yong-Sok Lee, Raphaël Tripier, Lawrence Szajek, Jeffrey Deschamps, et al.. Reply to the 'Comment on "Investigation of Zr(IV) and 89 Zr(IV) complexation with hydroxamates: progress towards designing a better chelator than desferrioxamine B for immuno-PET imaging"' by A. Bianchi and M. Savastano, Chem. Commun., 2020, 56, D0CC01189D. Chemical Communications, 2020, Online ahead of print. ⟨10.1039/d0cc03594g⟩. ⟨inserm-02947405⟩
97 View
75 Download

Altmetric

Share

Gmail Facebook X LinkedIn More